Announcements, news, events, and other publications produced by our office.

Media Center

Welcome to the Harvard OTD Media Center. This section provides the latest news on OTD announcements, including new partnerships and agreements and also serves as the home for recent media coverage and details on upcoming events.

Press Releases

03.04.2013Life Technologies Signs License and Collaborative Stem Cell Research Agreement with Harvard University
10.10.2012UCB Announces Third Research Collaboration With Harvard University
07.10.2012CureBeta, a collaboration between Evotec and Harvard University enters strategic alliance with Janssen Pharmaceuticals
07.09.2012Boehringer Ingelheim Establishes Translational Research Collaboration with Harvard University in Areas of Unmet Medical Need
06.30.2011UCB Launches Research Alliance with Harvard University

In the News

03.11.2013Renewed Harvard-BASF initiative to advance functional materials
Established with leadership from Harvard’s Office of Technology Development, the new, multi-university initiative builds on the successful model pioneered by the BASF Advanced Research Initiative that was based at Harvard SEAS from October 2007 to present.
02.25.2013With Fluorine Tech, SciFluor Aims to Vindicate “Me-Too” Drugs
One of Harvard's newly formed startup companies, SciFluor Life Sciences, and a success story of its Biomedical Accelerator program, leads the way in flourine technology.
12.13.2012INSERO HEALTH Completes Phase I Trial of Novel Therapy In Patients With Drug Resistant Epilepsy
Harvard's newly formed startup company, Insero Health, furthers development of Huperzine A -- a potential epilepsy drug candidate from the Harvard Medical School lab of Dr. Steven Schachter.
08.09.2012Collaboration for CureBeta between Evotec, Harvard University and Janssen Pharmaceuticals seeks nothing less than a cure for diabetes
Ultimately the agreement could lead to a total of USD 300 million per product for the university and its biotech partner
08.09.2012Collaborative research forges new ground
Unlike conventional sponsored research agreements in which companies fund research at universities to access cutting edge science, the results of which can be utilized for their R&D, the arrangement between Harvard and Hamburg-based Evotec was established as a true collaborative alliance.